Metabolic Solutions Development Company, LLC is a drug discovery and development company exploiting novel molecular targets to develop new therapies for metabolic diseases associated with altered mitochondrial function, especially insulin resistance and type 2 diabetes. Founded in 2006 by Jerry Colca, PhD and Rolf Kletzien, PhD, former researchers at The Upjohn Company, MSDC is envisioned to be a new kind of pharmaceutical company – one driven by innovative science and built by harnessing the external infrastructure that has grown in the wake of the contraction of the old “Big Pharma” system. MSDC is headquartered in Kalamazoo, Michigan.